GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » RUA Life Sciences PLC (LSE:RUA) » Definitions » PB Ratio

RUA Life Sciences (LSE:RUA) PB Ratio : 0.70 (As of May. 09, 2024)


View and export this data going back to 2002. Start your Free Trial

What is RUA Life Sciences PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-09), RUA Life Sciences's share price is £0.1175. RUA Life Sciences's Book Value per Share for the quarter that ended in Sep. 2023 was £0.17. Hence, RUA Life Sciences's PB Ratio of today is 0.70.

The historical rank and industry rank for RUA Life Sciences's PB Ratio or its related term are showing as below:

LSE:RUA' s PB Ratio Range Over the Past 10 Years
Min: 0.43   Med: 1.51   Max: 11.14
Current: 0.69

During the past 13 years, RUA Life Sciences's highest PB Ratio was 11.14. The lowest was 0.43. And the median was 1.51.

LSE:RUA's PB Ratio is ranked better than
88.26% of 792 companies
in the Medical Devices & Instruments industry
Industry Median: 2.24 vs LSE:RUA: 0.69

During the past 12 months, RUA Life Sciences's average Book Value Per Share Growth Rate was -32.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 11.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 8.30% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -5.00% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of RUA Life Sciences was 255.70% per year. The lowest was -50.40% per year. And the median was -6.60% per year.

Back to Basics: PB Ratio


RUA Life Sciences PB Ratio Historical Data

The historical data trend for RUA Life Sciences's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RUA Life Sciences PB Ratio Chart

RUA Life Sciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.94 4.46 3.69 1.65 2.44

RUA Life Sciences Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.39 1.65 1.66 2.44 0.94

Competitive Comparison of RUA Life Sciences's PB Ratio

For the Medical Devices subindustry, RUA Life Sciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RUA Life Sciences's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, RUA Life Sciences's PB Ratio distribution charts can be found below:

* The bar in red indicates where RUA Life Sciences's PB Ratio falls into.



RUA Life Sciences PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

RUA Life Sciences's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2023)
=0.1175/0.168
=0.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


RUA Life Sciences  (LSE:RUA) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


RUA Life Sciences PB Ratio Related Terms

Thank you for viewing the detailed overview of RUA Life Sciences's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


RUA Life Sciences (LSE:RUA) Business Description

Traded in Other Exchanges
Address
2 Drummond Crescent, Scotland, Irvine, Ayrshire, GBR, KA11 5AN
RUA Life Sciences PLC is a biomedical polymer technology, components, and medical device company. The company's principal activities comprise exploiting the value of its IP and know-how, medical device contract manufacturing, and development of cardiovascular devices. Its business segments are Royalty and License Income (Biomaterials), Contract Manufacture, Product Development (Vascular), and Product Innovation (Structural Heart). It derives the majority of its revenue from the Contract Manufacture segment. Geographically, it derives its major revenue from the USA and has a presence in Europe and the Rest of the world.

RUA Life Sciences (LSE:RUA) Headlines

No Headlines